We are a clinical-stage biopharmaceutical company exploring new ways to treat inflammatory and immune-related diseases. Edesa’s monoclonal antibody candidates have been developed as host-directed therapeutics targeting immune dysregulation.

Trabajamos todos los días Conocé las obras programadas. Conocé + Simulador de consumo Usá bien tu energía. Conocé + Simulador de facturación.

Edesa is exploring new ways to treat inflammatory and autoimmune diseases, including innovative alternatives to steroids, which can have serious side-effects. Our current clinical studies are designed to further evaluate safety and efficacy.

Find the latest Edesa Biotech, Inc. (EDSA) stock quote, history, news and other vital information to help you with your stock trading and investing.

We are advancing first-in-class therapies for Medical Dermatology and Respiratory diseases. Our clinical-stage drugs target critical points in inflammatory and innate immune response pathways, such as CXCL10 and TLR4. Our goal is to transform the lives of patients suffering from acute and chronic diseases.

In a world where comfort and efficiency are essential, EDESA takes pride in offering you the widest and most advanced selection of products to transform your home. Discover the most comprehensive range. Capacity of up to 10 kg for large families and multiple formats.

Edesa S.A is a Spanish manufacturer of domestic and commercial appliances. [1] After 60 years, it became a popular product in other countries. It is currently one of the top five brands in Spain in its sector.

Edessa (/ əˈdɛsə /; Ancient Greek: Ἔδεσσα, romanized: Édessa) was an ancient city (polis) in Upper Mesopotamia, in what is now Urfa or Şanlıurfa, Turkey. It was founded during the Hellenistic period by Macedonian general and self proclaimed king Seleucus I Nicator (r. 305–281 BC), founder of the Seleucid Empire.

Apr 15, 2025 · Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.

May 10, 2024 · Edesa Biotech’s Founder Makes Strategic Investment in the Company. October 31, 2024. Edesa Biotech Announces Upcoming Conference Schedule. October 21, 2024. Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results. August 09, 2024. BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS. June 24, 2024